InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (92 ops.)
Insider track record
CEODisclosed buys
5
Disclosed sells
92
T+90 hit rate
13%
T+90 mean return
-5.0%
Across 30 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by SMITH PATRICK W, Chief Executive Officer. Director active across 2 companies, notably Axon Enterprise, INC.. Aggregated, 139 filings have been logged. Split: 5 buys · 92 sells. Total volume traded: €188.5m. History available since 17 May 2021. The latest transaction was filed on 4 June 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations139 total
10,000 sharesCommon StockSEC:0001628280-26-046277:0
20,000 shares@ US$500.000.024% mcap1.0% of flowCommon StockSEC:0001628280-26-041656:0
10,000 shares@ US$500.241.0% of flowCommon StockSEC:0001628280-26-012411
10,000 shares@ US$500.240.013% mcap1.0% of flowCommon StockSEC:0001628280-26-012411:0
294 shares@ US$549.55890.0% of flowCommon StockSEC:0001628280-25-056207:0
1,887 shares@ US$550.67540.1% of flowCommon StockSEC:0001628280-25-056207:1
4,522 shares@ US$551.61590.2% of flowCommon StockSEC:0001628280-25-056207:2
1,402 shares@ US$552.41710.1% of flowCommon StockSEC:0001628280-25-056207:3
1,121 shares@ US$553.40980.1% of flowCommon StockSEC:0001628280-25-056207:4
634 shares@ US$554.37610.0% of flowCommon StockSEC:0001628280-25-056207:5
140 shares@ US$555.190.0% of flowCommon StockSEC:0001628280-25-056207:6
1,546 shares@ US$745.79740.1% of flowCommon StockSEC:0001167028-25-000003:8
283 shares@ US$734.2910.0% of flowCommon StockSEC:0001167028-25-000003:0
14 shares@ US$735.94540.0% of flowCommon StockSEC:0001167028-25-000003:1
1,353 shares@ US$739.39330.1% of flowCommon StockSEC:0001167028-25-000003:2
449 shares@ US$740.6180.0% of flowCommon StockSEC:0001167028-25-000003:3
1,403 shares@ US$741.81550.1% of flowCommon StockSEC:0001167028-25-000003:4
918 shares@ US$742.94690.1% of flowCommon StockSEC:0001167028-25-000003:5
372 shares@ US$743.53140.0% of flowCommon StockSEC:0001167028-25-000003:6
1,865 shares@ US$744.90060.1% of flowCommon StockSEC:0001167028-25-000003:7
779 shares@ US$746.77080.1% of flowCommon StockSEC:0001167028-25-000003:9
544 shares@ US$747.96870.0% of flowCommon StockSEC:0001167028-25-000003:10
331 shares@ US$748.90880.0% of flowCommon StockSEC:0001167028-25-000003:11
143 shares@ US$749.820.0% of flowCommon StockSEC:0001167028-25-000003:12
305 shares@ US$821.68480.0% of flowCommon StockSEC:0001069183-25-000190:0
25 of 139 declarations
About SMITH PATRICK W
Public sources confirm that Patrick W. Smith is the co-founder of Axon Enterprise and has served as its chief executive officer and a director since 1993. Axon’s proxy statement also says he graduated from Harvard, earned degrees at the University of Chicago and the University of Leuven, and holds 53 U.S. patents. For OncoCyte, SEC filings tie him to the company as an investor and trust holder, and a 2025 10-K says he participated in the February 2025 offering at $2.05 per share. Sources: https://www.sec.gov/Archives/edgar/data/1069183/000155837024004374/axon-20240510xdef14a.htm
